Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study

Detalles Bibliográficos
Autores principales: Nakamura, Akihiro, Kagaya, Yuta, Saito, Hiroki, Kanazawa, Masanori, Sato, Kenjiro, Miura, Masanobu, Kondo, Masateru, Endo, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244067/
https://www.ncbi.nlm.nih.gov/pubmed/37150612
http://dx.doi.org/10.5551/jat.ER63659
_version_ 1785054560948060160
author Nakamura, Akihiro
Kagaya, Yuta
Saito, Hiroki
Kanazawa, Masanori
Sato, Kenjiro
Miura, Masanobu
Kondo, Masateru
Endo, Hideaki
author_facet Nakamura, Akihiro
Kagaya, Yuta
Saito, Hiroki
Kanazawa, Masanori
Sato, Kenjiro
Miura, Masanobu
Kondo, Masateru
Endo, Hideaki
author_sort Nakamura, Akihiro
collection PubMed
description
format Online
Article
Text
id pubmed-10244067
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Japan Atherosclerosis Society
record_format MEDLINE/PubMed
spelling pubmed-102440672023-06-08 Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study Nakamura, Akihiro Kagaya, Yuta Saito, Hiroki Kanazawa, Masanori Sato, Kenjiro Miura, Masanobu Kondo, Masateru Endo, Hideaki J Atheroscler Thromb Erratum Japan Atherosclerosis Society 2023-06-01 2023-05-02 /pmc/articles/PMC10244067/ /pubmed/37150612 http://dx.doi.org/10.5551/jat.ER63659 Text en 2023 Japan Atherosclerosis Society https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Erratum
Nakamura, Akihiro
Kagaya, Yuta
Saito, Hiroki
Kanazawa, Masanori
Sato, Kenjiro
Miura, Masanobu
Kondo, Masateru
Endo, Hideaki
Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study
title Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study
title_full Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study
title_fullStr Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study
title_full_unstemmed Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study
title_short Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study
title_sort efficacy and safety of pemafibrate versus bezafibrate to treat patients with hypertriglyceridemia: a randomized crossover study
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244067/
https://www.ncbi.nlm.nih.gov/pubmed/37150612
http://dx.doi.org/10.5551/jat.ER63659
work_keys_str_mv AT nakamuraakihiro efficacyandsafetyofpemafibrateversusbezafibratetotreatpatientswithhypertriglyceridemiaarandomizedcrossoverstudy
AT kagayayuta efficacyandsafetyofpemafibrateversusbezafibratetotreatpatientswithhypertriglyceridemiaarandomizedcrossoverstudy
AT saitohiroki efficacyandsafetyofpemafibrateversusbezafibratetotreatpatientswithhypertriglyceridemiaarandomizedcrossoverstudy
AT kanazawamasanori efficacyandsafetyofpemafibrateversusbezafibratetotreatpatientswithhypertriglyceridemiaarandomizedcrossoverstudy
AT satokenjiro efficacyandsafetyofpemafibrateversusbezafibratetotreatpatientswithhypertriglyceridemiaarandomizedcrossoverstudy
AT miuramasanobu efficacyandsafetyofpemafibrateversusbezafibratetotreatpatientswithhypertriglyceridemiaarandomizedcrossoverstudy
AT kondomasateru efficacyandsafetyofpemafibrateversusbezafibratetotreatpatientswithhypertriglyceridemiaarandomizedcrossoverstudy
AT endohideaki efficacyandsafetyofpemafibrateversusbezafibratetotreatpatientswithhypertriglyceridemiaarandomizedcrossoverstudy